EUVIMEDEUVIMED entdecken
Crossref

HPLC-UV/VIS for Determination of Ipratropium Bromide Mixed with Salbuterol, Beclomethasone Propionate and Budesonide using Dual Wavelength-Detection Method

Guo Haihua, Zhang Rui, Deng Liangjun, Li Meng, Li Sha, Zhao Suqing

Drug Research · 01.07.2023 · 73 (06) · 335-340

DOI: 10.1055/a-2007-1820 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Research, erschienen am 01.07.2023. Verfasst von Guo Haihua und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Biomedical and Pharmaceutical Science, Guangdong University of Technology, Higher Education Mega Center, Guangzhou, China. Hauptthemen laut MEDLINE: Ipratropium, Budesonide. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 17 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Inhalation preparation involves liquid or solid raw materials for delivering to lungs as aerosol or vapor. The liquid preparation for nebulizer is effective for convenient use and patient compliance and it has been extensively used in the treatment of clinical lung diseases. Clinical staff often mixes the compound ipratropium bromide with beclomethasone propionate and budesonide inhaler but reference values of inhalants for clinical use need to be established for simplifying the operation procedure. The high-performance liquid chromatography (HPLC) method of compound ipratropium bromide solution, beclomethasone propionate suspension and budesonide suspension after mixed atomization was studied.

Methods

The specificity, linearity, recovery (accuracy), precision and stability of compound ipratropium bromide, beclomethasone propionate and budesonide were tested to verify the developed liquid phase method.

Results

The developed liquid phase method had high specificity, linear R2≥0,999, recovery (accuracy) RSD (relative standard deviation) less than 2%, precision RSD less than 2,0%, and stability RSD less than 2,0%.

Conclusion

The liquid phase methodology developed in this study can be used for the determination of compound ipratropium bromide mixed with beclomethasone propionate and budesonide. The current methodology can also be used to provide a reference for the determination of its content after mixing, and further data support for its clinical medication.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IpratropiumBudesonideHumansBeclomethasoneBronchodilator AgentsChromatography, High Pressure LiquidPropionates

Substanzen

IpratropiumBudesonideBeclomethasoneBronchodilator AgentsPropionates

Autor:innen und Institutionen

  • College of Biomedical and Pharmaceutical Science, Guangdong University of Technology, Higher Education Mega Center, Guangzhou, China.
  • College of pharmacy, Sun Yet-Sen University, Higher Education Mega Center, Guangzhou, China.

Zitieren

APA

Haihua, G., Rui, Z., Liangjun, D., Meng, L., Sha, L., & Suqing, Z. (2023). HPLC-UV/VIS for Determination of Ipratropium Bromide Mixed with Salbuterol, Beclomethasone Propionate and Budesonide using Dual Wavelength-Detection Method. Drug Research, 73(06), 335-340. https://doi.org/10.1055/a-2007-1820

Vancouver

Haihua G, Rui Z, Liangjun D, Meng L, Sha L, Suqing Z. HPLC-UV/VIS for Determination of Ipratropium Bromide Mixed with Salbuterol, Beclomethasone Propionate and Budesonide using Dual Wavelength-Detection Method. Drug Research. 2023;73(06):335-340. doi:10.1055/a-2007-1820

BibTeX
@article{Haihua2023,
  author = {Haihua, Guo and Rui, Zhang and Liangjun, Deng and Meng, Li and Sha, Li and Suqing, Zhao},
  title = {HPLC-UV/VIS for Determination of Ipratropium Bromide Mixed with Salbuterol, Beclomethasone Propionate and Budesonide using Dual Wavelength-Detection Method},
  journal = {Drug Research},
  year = {2023},
  volume = {73},
  number = {06},
  pages = {335--340},
  doi = {10.1055/a-2007-1820}
}
Kostenlos starten →